Profil
Scott Schaus was the founder of Seaport Diagnostics, Inc., founded in 2014, where the title held was Chief Scientific Officer.
Mr. Schaus is the founder of Virex Health LLC, founded in 2022, holding the title of Chief Technology Officer.
Mr. Schaus is currently Chief Technology Officer at Sorrento Therapeutics, Inc. since 2022.
Formerly, Mr. Schaus was a Professor at Boston University.
Aktive Positionen von Scott Schaus
| Unternehmen | Position | Beginn |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
Virex Health LLC
Virex Health LLC Medical/Nursing ServicesHealth Services Provides health diagnostics services | Gründer | 01.01.2022 |
Ehemalige bekannte Positionen von Scott Schaus
| Unternehmen | Position | Ende |
|---|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Health Services |
Virex Health LLC
Virex Health LLC Medical/Nursing ServicesHealth Services Provides health diagnostics services | Health Services |
















